Cat.#: ACPP-1818
Despition | FGF 9 Mouse Recombinant |
SIZE | 2 µg |
Sequence | Pro-Leu-Gly-Glu-Val. |
Purity | > 95.0% (SDS-PAGE) |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1095 | Synthetic Nanodisc Human MLC1 Protein (AC1095) | 10 µg | inquiry |
ACPP-1800 | Human RCN3 Protein (AC1800) | 5 µg | inquiry |
ACPP-1606 | Human GAD2 Protein (AC1606) | 50 µg | inquiry |
ACPP-1124 | Recombinant Human MAP2C Protein (AC1124) | 25 µl | inquiry |
ACPP-1806 | Human SCGN Protein (AC1806) | 2 µg | inquiry |
ACPP-1459 | Human Midkine Protein, His (AC1459) | 5 µg | inquiry |
ACPP-1066 | Recombinant Human FGF2 Protein (Fc Tag) (AC1066) | 50 µg | inquiry |
ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
ACPP-1214 | Ki67 Blocking Peptide (AC1214) | 250 µg | inquiry |
ACPP-1573 | Human YWHAG Protein, His (AC1573) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.